Skip to main content

Table 1 Changes of serum and cardiac FFA composition in CON and DM groups (n = 12)

From: Reduction of n-3 PUFAs, specifically DHA and EPA, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart

Fatty acid

       Serum (μmol/ml)

       Heart (μmol/g prot)

CON

DM

CON

DM

C16:0(palmitic acid)

324 ± 21

453 ± 56 **

1481 ± 108

1593 ± 118

C18:0(octadecanoic acid)

202 ± 22

334 ± 31 **

2193 ± 197

2835 ± 129**

C20:0(arachidic acid)

3.9 ± 0.2

5.1 ± 0.2 *

13.0 ± 1.1

14.4 ± 1.3

C22:0(behenic acid)

4.7 ± 0.4

7.5 ± 0.9 **

21.9 ± 1.5

21.7 ± 2.9

C24:0(lignoceric acid)

9.1 ± 1.7

8.8 ± 0.7

36.4 ± 4.7

26.0 ± 1.6**

C16:1n-7(palmitoleic acid)

13.1 ± 1.8

12.2 ± 3.0

42.6 ± 10.8

41.5 ± 4.3

C18:1n-9(oleic acid, OA)

83.4 ± 23.3

259 ± 69 **

859 ± 113

1994 ± 209**

C18:2n-6(linoleic acid, LA)

255 ± 28

231 ± 20

1473 ± 99

1724 ± 229**

C20:4n-6(arachidonic acid, AA)

227 ± 15

250 ± 19

1330 ± 130

1318 ± 145

C22:4n-6(docosatetraenoic acid)

1.4 ± 1.1

10.0 ± 1.3**

49.5 ± 8.1

127 ± 11**

C18:3n-3(α-linolenic acid, LNA)

7.4 ± 0.7

2.8 ± 0.4 **

20.5 ± 6.5

11.3 ± 2.2**

C20:5n-3(eicosapentaenoic acid, EPA)

10.1 ± 1.1

8.2 ± 0.5 **

10.0 ± 1.4

ND

C22:5n-3(docosapentaenoic acid, DPA)

3.6 ± 1.3

3.5 ± 1.3

81.7 ± 7.5

47.2 ± 6.9**

C22:6n-3(docosahexaenoic acid, DHA)

47.4 ± 2.1

50.6 ± 3.8

613 ± 62

317 ± 61**

n-6/n-3

7.1

7.9

3.9

8.4

  1. Data represent the means ± SD. * P < 0.05 vs. CON; ** P < 0.01 vs. CON. ND: not detected.